RUSSELL BRANT: Open Payments
NPI 1508859927 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 15 payments from 8 companies in 2025. Trend: 2023 $214 · 2024 $582 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $81 |
| Gilead Sciences, Inc. | 2 | $47 |
| PFIZER INC. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Corcept Therapeutics | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, JARDIANCE, Yeztugo, VOQUEZNA, Korlym, VYNDAQEL, PREVNAR 20, MAVYRET.
Industry payments across SC — which companies pay providers there.
